Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Macrolides: indications in 1997]

D Bouhour1, D Peyramond

  • 1Service de Maladies infectieuses et tropicales, Hôpital de la Croix-Rousse, Lyon.

Presse Medicale (Paris, France : 1983)
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suspected SARS patients hospitalised in French isolation units during the early SARS epidemic: The French experience.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same author

Treatment of 112 bone and joint infections with teicoplanin.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2013
Same author

Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.

QJM : monthly journal of the Association of Physicians·2013
Same author

Survey of vaccination policies in French healthcare institutions.

Medecine et maladies infectieuses·2012
Same author

[Current events in vaccination].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2011
Same author

[Current events in vaccination].

Medecine et maladies infectieuses·2011
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Macrolide antibiotics, including semi-synthetic derivatives like roxithromycin, offer improved profiles for treating respiratory infections. Emerging research explores their potential against atypical pathogens such as Mycobacterium avium and Helicobacter pylori.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Context:

  • The macrolide antibiotic class, initiated by erythromycin, has expanded significantly with semi-synthetic derivatives.
  • Roxithromycin, a notable derivative, exhibits enhanced absorption, tolerability, and stability compared to its predecessors.

Purpose:

  • To review current indications for macrolide antibiotics, particularly for respiratory tract infections, based on recent consensus.
  • To explore emerging trends and new therapeutic perspectives for macrolides beyond respiratory applications.

Summary:

  • Macrolides are effective against common respiratory pathogens, with roxithromycin offering clinical advantages.
  • New research highlights macrolides' potential utility against challenging bacteria like Mycobacterium avium intracellulare, Helicobacter pylori, Chlamydia pneumoniae, and Mycoplasma pneumoniae.

Related Experiment Videos

Impact:

  • Provides an updated overview of macrolide antibiotic applications for clinicians.
  • Highlights the evolving role of macrolides in combating both traditional and emerging bacterial infections.